93 7439 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint 93 7439 is Orange, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Teva Pharmaceuticals USA.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7439

Divalproex Sodium Delayed-Release

Imprint:

93 7439

Strength:

125 mg

Color:

Orange

Size:

12.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

ammonia
crospovidone
hypromellose 2910 (15 mPa.s)
hypromellose phthalate (31% phthalate, 40 cst)
ferrosoferric oxide
lactose monohydrate
magnesium stearate
microcrystalline cellulose
polyethylene glycol 3350
polyethylene glycol 4000
polyvinyl alcohol
povidone k30
corn starch
propylene glycol
shellac
silicon dioxide
magnesium silicate
titanium dioxide
triethyl citrate
D&C Yellow No. 10
aluminum oxide
FD&C Red No. 40
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer